Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients

被引:8
作者
Tong, Jianhua [1 ]
Liu, Panmiao [1 ]
Ji, Muhuo [1 ]
Wang, Ying [1 ]
Xue, Qiong [1 ]
Yang, Jian-Jun [1 ]
Zhou, Cheng-Mao [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol Pain & Perioperat Med, Zhengzhou 450000, Henan, Peoples R China
关键词
Treatment algorithms; radiofrequency ablation; hepatocellular carcinoma; individual outcomes; patient stratification;
D O I
10.1177/11795549211000017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVE: Over 1 million new cases of hepatocellular carcinoma (HCC) are diagnosed worldwide every year. Its prognosis remains poor. and the 5-year survival rate in all disease stages is estimated to be between 10% and 20%. Radiofrequency ablation (RFA) has become an important local treatment for liver cancer, and machine learning (ML) can provide many shortcuts for liver cancer medical research. Therefore. we explore the role of ML in predicting the total mortality of liver cancer patients undergoing RFA. METHODS: This study is a secondary analysis of public database data from 578 liver cancer patients. We used Python for ML to establish the prognosis model. RESULTS: The results showed that the 5 most important factors were platelet count (PLT), Alpha-fetoprotein (AFP). age, tumor size, and total bilirubin. respectively. Results of the total death model for liver cancer patients in test group: among the 5 algorithm models, the highest accuracy rate was that of gbm (0.681), followed by the Logistic algorithm (0.672); among the 5 algorithms, area under the curve (AUC) values, from high to low, were Logistic (0.738), DecisionTree (0.723), gbm (0.717), GradientBoosting (0.714). and Forest (0.693); Among the 5 algorithms, gbm had the highest precision rate (0.721), followed by the Logistic algorithm (0.714). Among the 5 algorithms. DecisionTree had the highest recall rate (0.642), followed by the GradientBoosting algorithm (0.571). CONCLUSION: Machine learning can predict total death after RFA in liver cancer patients. Therefore, ML research has great potential for both personalized treatment and prognosis of liver cancer.
引用
收藏
页数:7
相关论文
共 29 条
[21]   Novel advancements in the management of hepatocellular carcinoma in 2008 [J].
Llovet, Josep M. ;
Bruix, Jordi .
JOURNAL OF HEPATOLOGY, 2008, 48 :S20-S37
[22]   The crucial role of multiomic approach in cancer research and clinically relevant outcomes [J].
Lu, Miaolong ;
Zhan, Xianquan .
EPMA JOURNAL, 2018, 9 (01) :77-102
[23]   Radiofrequency ablation of hepatocellular carcinoma: Current status [J].
Minami, Yasunori ;
Kudo, Masatoshi .
WORLD JOURNAL OF RADIOLOGY, 2010, 2 (11) :417-424
[24]   Predicting the Future - Big Data, Machine Learning, and Clinical Medicine [J].
Obermeyer, Ziad ;
Emanuel, Ezekiel J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (13) :1216-1219
[25]   Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective [J].
Poon, RTP ;
Fan, ST ;
Tsang, FHF ;
Wong, J .
ANNALS OF SURGERY, 2002, 235 (04) :466-486
[26]   Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles [J].
Qian, Shehua ;
Golubnitschaja, Olga ;
Zhan, Xianquan .
EPMA JOURNAL, 2019, 10 (04) :365-381
[27]   Postoperative Decrease in Platelet Counts Is Associated with Delayed Liver Function Recovery and Complications after Partial Hepatectomy [J].
Takahashi, Kazuhiro ;
Kurokawa, Tomohiro ;
Oshiro, Yukio ;
Fukunaga, Kiyoshi ;
Sakashita, Shingo ;
Ohkohchi, Nobuhiro .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 239 (01) :47-55
[28]   Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers [J].
Wan, Shaogui ;
Lai, Yinzhi ;
Myers, Ronald E. ;
Li, Bingshan ;
Palazzo, Juan P. ;
Burkart, Ashlie L. ;
Chen, Guokai ;
Xing, Jinliang ;
Yang, Hushan .
BMC CANCER, 2013, 13
[29]   Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning [J].
Zhou, Chengmao ;
Wang, Ying ;
Ji, Mu-Huo ;
Tong, Jianhua ;
Yang, Jian-Jun ;
Xia, Hongping .
CANCER CONTROL, 2020, 27 (01)